Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 376 matching trials from the live ClinicalTrials.gov search.
Filters: Intervention: Mammogram Clear all
Completed No phase listed Observational Accepts healthy volunteers

Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

NCT00943527
View directory record Official record
Conditions
Breast Cancer
Interventions
Not listed
Lead sponsor
Mayo Clinic
Other
Eligibility
35 Years to 45 Years · Female only
Enrollment
110 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2008 – 2012
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Jan 25, 2012 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional

Increasing Screening for Cancer Using EHR-Nudges Replication

NCT06995703
View directory record Official record
Conditions
Breast Cancer
Interventions
Pre-Visit Patient Text Message, Post-Visit Patient Text Messages, Smart Data Element (SDE)
Behavioral
Lead sponsor
Abramson Cancer Center at Penn Medicine
Other
Eligibility
40 Years to 74 Years · Female only
Enrollment
8,490 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
1
States / cities
Lancaster, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Aug 12, 2026 · Synced Oct 19, 2026, 6:38 PM EDT
Withdrawn Not applicable Interventional

Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD)

NCT00610831
View directory record Official record
Conditions
Breast Cancer
Interventions
DIRECTVIEW CR Mammography
Device
Lead sponsor
University of California, Irvine
Other
Eligibility
40 Years to 85 Years · Female only
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2008
U.S. locations
1
States / cities
Orange, California
Source: ClinicalTrials.gov public record
Updated Jan 31, 2018 · Synced Oct 19, 2026, 6:38 PM EDT
Active, not recruiting Not applicable Interventional

Mammography and Breast Arterial Calcification: An Information-Sharing Trial

NCT04983875
View directory record Official record
Conditions
Mammography, Vascular Calcification
Interventions
BAC-Enhanced Letter, Waitlist Control
Behavioral
Lead sponsor
Icahn School of Medicine at Mount Sinai
Other
Eligibility
40 Years and older · Female only
Enrollment
5,492 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2027
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Apr 16, 2026 · Synced Oct 19, 2026, 6:38 PM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

Opt-in vs. Opt-out for Breast Cancer Screening

NCT05313737
View directory record Official record
Conditions
Breast Cancer
Interventions
Automated message, Opt-out scheduling
Other
Lead sponsor
VA Puget Sound Health Care System
Federal
Eligibility
45 Years to 75 Years · Female only
Enrollment
871 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022
U.S. locations
1
States / cities
Seattle, Washington
Source: ClinicalTrials.gov public record
Updated Apr 6, 2022 · Synced Oct 19, 2026, 6:38 PM EDT
Withdrawn No phase listed Observational

Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer

NCT00934401
View directory record Official record
Conditions
Breast Neoplasms
Interventions
Not listed
Lead sponsor
University of Iowa
Other
Eligibility
18 Years to 100 Years · Female only
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2010
U.S. locations
1
States / cities
Iowa City, Iowa
Source: ClinicalTrials.gov public record
Updated Jul 11, 2016 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall

NCT00208871
View directory record Official record
Conditions
Breast Cancer
Interventions
Stereoscopic Digital Mammography
Procedure
Lead sponsor
Emory University
Other
Eligibility
Female only
Enrollment
1,467 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2004 – 2011
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Nov 20, 2013 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional

Breast Lesion Analysis for Tomosynthesis Mammography

NCT00723541
View directory record Official record
Conditions
Breast Cancer, Abnormal Findings on Radiological Examination of Breast
Interventions
Computer aided analysis of breast lesions
Procedure
Lead sponsor
University of Michigan
Other
Eligibility
21 Years and older · Female only
Enrollment
872 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2016
U.S. locations
1
States / cities
Ann Arbor, Michigan
Source: ClinicalTrials.gov public record
Updated Jan 21, 2020 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Phase 4 Interventional

Dotarem vs Gadobutrol Contrast for Breast MRI

NCT03730051
View directory record Official record
Conditions
Breast Diseases
Interventions
Gadoterate meglumine, Gadobutrol
Drug
Lead sponsor
University of Massachusetts, Worcester
Other
Eligibility
18 Years and older · Female only
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2025
U.S. locations
1
States / cities
Worcester, Massachusetts
Source: ClinicalTrials.gov public record
Updated Mar 17, 2026 · Synced Oct 19, 2026, 6:38 PM EDT
Recruiting Not applicable Interventional

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

NCT04959474
View directory record Official record
Conditions
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage 2 Breast Cancer AJCC v8, Anatomic Stage 3 Breast Cancer AJCC v8, Breast Ductal Carcinoma in Situ, Invasive Breast Carcinoma, Triple Negative Breast Carcinoma
Interventions
Best Practice, Stereotactic Body Radiation Therapy, Resection, Sentinel Lymph Node Biopsy, Dietary Intervention, Questionnaire Administration, Quality-of-Life Assessment, Mammography, Biospecimen Collection
Other · Radiation · Procedure
Lead sponsor
Thomas Jefferson University
Other
Eligibility
40 Years and older
Enrollment
80 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2028
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jan 23, 2026 · Synced Oct 19, 2026, 6:38 PM EDT
Completed No phase listed Observational

Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

NCT02690805
View directory record Official record
Conditions
Breast Cancer
Interventions
MR-compatible scinti-mammography (MRI-SMM) system
Device
Lead sponsor
University of California, Irvine
Other
Eligibility
21 Years and older · Female only
Enrollment
16 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2019
U.S. locations
1
States / cities
Irvine, California
Source: ClinicalTrials.gov public record
Updated Apr 19, 2021 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing

NCT01653964
View directory record Official record
Conditions
Breast Cancer
Interventions
Molecular breast imaging
Diagnostic Test
Lead sponsor
Mayo Clinic
Other
Eligibility
40 Years and older · Female only
Enrollment
83 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2012 – 2016
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Sep 18, 2017 · Synced Oct 19, 2026, 6:38 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer

NCT05615298
View directory record Official record
Conditions
Breast Cancer
Interventions
Mammography
Radiation
Lead sponsor
Lunit Inc.
Industry
Eligibility
Female only
Enrollment
240 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2021
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Nov 14, 2022 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional

The Change Cycle Intervention for Improving Quality of Life in Breast Cancer Survivors

NCT01734499
View directory record Official record
Conditions
Breast Cancer
Interventions
Coping Class, Standard of Care, FACT-B Quality of Life
Behavioral
Lead sponsor
Texas Tech University Health Sciences Center
Other
Eligibility
18 Years and older · Female only
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2015
U.S. locations
1
States / cities
Amarillo, Texas
Source: ClinicalTrials.gov public record
Updated Apr 21, 2016 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

NCT02587663
View directory record Official record
Conditions
Ductal Breast Carcinoma In Situ, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer
Interventions
Contrast-enhanced Magnetic Resonance Imaging, Mammography, Therapeutic Conventional Surgery, Ultrasonography, Gadolinium
Procedure · Other
Lead sponsor
University of Southern California
Other
Eligibility
18 Years and older · Female only
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2012
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated May 16, 2019 · Synced Oct 19, 2026, 6:38 PM EDT
Completed No phase listed Observational

Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects

NCT02302196
View directory record Official record
Conditions
Cancer of the Breast, Anomaly of Breast
Interventions
Autologous Fat Grafting of the Breast, Control Arm
Procedure · Other
Lead sponsor
Kaiser Permanente
Other
Eligibility
18 Years and older · Female only
Enrollment
27 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2021
U.S. locations
1
States / cities
Clackamas, Oregon
Source: ClinicalTrials.gov public record
Updated Aug 20, 2021 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional

Use of a Radiolucent Pad to Reduce Mammography Among African Americans

NCT00594282
View directory record Official record
Conditions
Breast Cancer
Interventions
Radiolucent cushion
Device
Lead sponsor
University of Kansas
Other
Eligibility
40 Years and older · Female only
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 2005
U.S. locations
1
States / cities
Kansas City, Kansas
Source: ClinicalTrials.gov public record
Updated Sep 12, 2008 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Intervention to Promote Breast Cancer Screening Among American Indian Women

NCT05530603
View directory record Official record
Conditions
Breast Cancer
Interventions
Educational mobile app
Behavioral
Lead sponsor
University of South Dakota
Other
Eligibility
40 Years to 70 Years · Female only
Enrollment
133 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2023
U.S. locations
2
States / cities
Lake Andes, South Dakota • Vermillion, South Dakota
Source: ClinicalTrials.gov public record
Updated Mar 17, 2025 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

NCT04002986
View directory record Official record
Conditions
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
Interventions
Genetic Testing
Genetic
Lead sponsor
Mayo Clinic
Other
Eligibility
35 Years and older · Female only
Enrollment
116 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2021
U.S. locations
1
States / cities
Scottsdale, Arizona
Source: ClinicalTrials.gov public record
Updated Jul 24, 2023 · Synced Oct 19, 2026, 6:38 PM EDT
Active, not recruiting Not applicable Interventional Accepts healthy volunteers

Breast Cancer Screening Decision Aid

NCT07515846
View directory record Official record
Conditions
Mammography Screening, Geriatrics, Decision Aid
Interventions
Video based decision aid, Written decision aid
Behavioral
Lead sponsor
Yale University
Other
Eligibility
75 Years and older · Female only
Enrollment
300 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2027
U.S. locations
1
States / cities
New Haven, Connecticut
Source: ClinicalTrials.gov public record
Updated Jun 23, 2026 · Synced Oct 19, 2026, 6:38 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT

NCT05716958
View directory record Official record
Conditions
Breast Cancer
Interventions
Digital Breast Tomosynthesis
Radiation
Lead sponsor
Lunit Inc.
Industry
Eligibility
22 Years and older · Female only
Enrollment
262 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2023
U.S. locations
1
States / cities
Annapolis, Maryland
Source: ClinicalTrials.gov public record
Updated Sep 19, 2024 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional

Breast Cancer Outreach Among Primary Care Patients

NCT05089903
View directory record Official record
Conditions
Breast Cancer
Interventions
Bulk Order, Texting, Clinician Endorsement, No Bulk Order, Standard Endorsement
Behavioral
Lead sponsor
Abramson Cancer Center at Penn Medicine
Other
Eligibility
40 Years to 74 Years · Female only
Enrollment
24,680 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jun 27, 2022 · Synced Oct 19, 2026, 6:38 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Evive Health Randomized Controlled Trials

NCT01653197
View directory record Official record
Conditions
People Due for Mammogram, People Due for Colonoscopy, People Due for Blood Pressure Test, People Due for Cholesterol Test
Interventions
Control, Curiosity, Curiosity linked to Action
Behavioral
Lead sponsor
University of Pennsylvania
Other
Eligibility
18 Years and older
Enrollment
29 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Sep 28, 2017 · Synced Oct 19, 2026, 6:38 PM EDT
Recruiting Phase 3 Interventional

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

NCT06058377
View directory record Official record
Conditions
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma
Interventions
Biospecimen Collection, Cyclophosphamide, Doxorubicin, Durvalumab, Genetic Testing, Mammography, Paclitaxel, Quality-of-Life Assessment
Procedure · Drug · Biological + 1 more
Lead sponsor
National Cancer Institute (NCI)
NIH
Eligibility
18 Years and older
Enrollment
3,680 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2032
U.S. locations
558
States / cities
Birmingham, Alabama • Anchorage, Alaska • Tucson, Arizona + 429 more
Source: ClinicalTrials.gov public record
Updated Oct 19, 2026 · Synced Oct 19, 2026, 6:38 PM EDT